ID: ALA555268

Max Phase: Preclinical

Molecular Formula: C13H20BrNO

Molecular Weight: 205.30

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Br.CCCN1CCC(c2cccc(O)c2)C1

Standard InChI:  InChI=1S/C13H19NO.BrH/c1-2-7-14-8-6-12(10-14)11-4-3-5-13(15)9-11;/h3-5,9,12,15H,2,6-8,10H2,1H3;1H

Standard InChI Key:  LCAFOHSUEGTCAZ-UHFFFAOYSA-N

Associated Targets(non-human)

Dopamine receptor 1304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 205.30Molecular Weight (Monoisotopic): 205.1467AlogP: 2.59#Rotatable Bonds: 3
Polar Surface Area: 23.47Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.19CX Basic pKa: 9.40CX LogP: 2.26CX LogD: 0.55
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.82Np Likeness Score: -0.65

References

1. Hacksell U, Arvidsson LE, Svensson U, Nilsson JL, Sanchez D, Wikström H, Lindberg P, Hjorth S, Carlsson A..  (1981)  3-Phenylpiperidines. Central dopamine-autoreceptor stimulating activity.,  24  (12): [PMID:6796690] [10.1021/jm00144a021]

Source